IP Library Granted Patent US 10,640,800
Granted Patent B2
US 10,640,800 · App. 15/213,947 · Granted May 5, 2020

Mice that produce hybrid antibodies

Inventors: Andrew J. Murphy (Croton-On-Hudson, NY); George D. Yancopoulos (Yorktown Heights, NY); Margaret Karow (Santa Rosa, CA); Lynn MacDonald (Harrison, NY); Sean Stevens (Del Mar, CA); Aris N. Economides (Tarrytown, NY); David M. Valenzuela (Yorktown Heights, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C12P21/00A01K67/0275A01K67/0278C07K16/00C07K16/28C07K16/462C12N15/67C12N15/85C12N15/8509C12N15/902C12N15/907A01K2207/15A01K2217/05A01K2227/105A01K2267/01C07K2317/10C07K2317/21C07K2317/24C07K2317/51C07K2317/515C07K2317/56C12N2800/204
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,640,800
App. No.
15/213,947
Granted
May 5, 2020
Kind
B2
Abstract

Provided herein is a mouse that produces hybrid antibodies containing human variable regions and mouse constant regions.

Claims (6)

1. A mouse comprising in its germline unrearranged human heavy chain variable region gene segments, wherein the unrearranged human heavy chain variable region gene segments in situ replace endogenous mouse heavy chain immunoglobulin variable region gene segments, and the unrearranged human heavy chain variable region gene segments are operably linked to an endogenous mouse heavy chain constant region gene, wherein rearrangement of the unrearranged human heavy chain variable region gene segments in the mouse results in a rearranged human heavy chain variable region gene operably linked to the mouse heavy chain constant region gene, wherein in response to exposure to an antigen the mouse produces a hybrid antibody to the antigen, wherein the hybrid antibody comprises a human heavy chain variable region encoded by the rearranged human heavy chain variable region gene and a mouse heavy chain constant region encoded by the mouse heavy chain constant region gene, and wherein the endogenous immunoglobulin enhancer Eμ remains intact upstream of the mouse heavy chain constant region gene.

2. The mouse of claim 1 , wherein the human heavy chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 20 kb.

3. The mouse of claim 1 , wherein the human heavy chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 100 kb.

4. The mouse of claim 1 , wherein the mouse further comprises in its germline unrearranged human light chain variable region gene segments operably linked to a mouse light chain constant region gene.

5. The mouse of claim 4 , wherein the human heavy chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 20 kb and the human light chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 20 kb.

6. The mouse of claim 4 , wherein the human heavy chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 100 kb and the human light chain variable region gene segments are contained on a human genomic DNA fragment that is larger than 100 kb.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2016
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.; KAROW, MARGARET; MACDONALD, LYNN; STEVENS, SEAN; ECONOMIDES, ARIS N.; VALENZUELA, DAVID M.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 039519/0178 →
Cited By (1)
US 12,441,784